Finance

Beta
Ask
Lists
175250:KOSDAQ
Icure Pharmaceutical Inc
₩2,170.00
0.00%
(0.00) 1D
Aug 5, 11:56:58 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 175250...
Mkt. cap
81.50B
Volume
0.00
52-wk high
₩2,255
52-wk low
₩1,786
EPS
-₩855
Shares outstanding
37.56M
No. of employees
220
Mkt. cap
81.50B
Volume
0.00
52-wk high
₩2,255
52-wk low
₩1,786
EPS
-₩855
Shares outstanding
37.56M
No. of employees
220
News stories
From sources across the web
About Icure Pharmaceutical Inc
CEOChoi Young-Kweon
Employees220
Founded2000
Headquarters-
SectorPersonal care products
Websiteicure.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
25.26B
25.14B
-
32.19B
Cost of goods sold
24.06B
24.10B
-
28.71B
Cost of revenue
24.06B
24.10B
-
28.71B
Research and development expenses
597.62M
770.41M
-
799.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.14B
2.44B
-
2.17B
Operating expense
6.21B
4.14B
-
3.28B
Total operating expenses
30.27B
28.24B
-
31.98B
Operating income
-5.02B
-3.11B
-
207.55M
Other non operating income
-825.76M
24.37M
-
-311.21M
EBT including unusual items
-9.81B
-3.87B
-
-668.69M
EBT excluding unusual items
-6.84B
-3.89B
-
-487.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
61.54M
108.62M
-
64.93M
Net income
-9.53B
-3.70B
-
-555.93M
Net profit margin
-37.75%
-14.73%
-
-1.73%
Earnings per share
-
-
-
-
Interest and investment income
59.95M
67.58M
-
68.98M
Interest expense
-877.58M
-893.38M
-
-449.50M
Net interest expenses
-817.63M
-825.80M
-
-380.52M
Depreciation and amortization charges
374.45M
441.71M
-
302.90M
EBITDA
-3.31B
-1.35B
-
1.11B
Gain or loss from assets sale
-1.29M
-15.34M
-
27.32M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer